• 1
    Goldstein DA, Thomas JA. Biopharmaceuticals derived from genetically modified plants. QJM 2004;97:705716.
  • 2
    Bakker H, Rouwendal GJ, Karnoup AS, Florack DE, Stoopen GM, Helsper JP et al. An antibody produced in tobacco expressing a hybrid {beta}-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci USA 2006;103:75777582.
  • 3
    Aalberse RC, Koshte V, Clemens JG. Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and hymenoptera venom. J Allergy Clin Immunol 1981;68:356364.
  • 4
    Mari A. IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol 2002;129:286295.
  • 5
    Van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002;129:189197.
  • 6
    Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007;142:99115.
  • 7
    Fotisch K, Altmann F, Haustein D, Vieths S. Involvement of carbohydrate epitopes in the IgE response of celery-allergic patients. Int Arch Allergy Immunol 1999;120:3042.
  • 8
    Ballmer-Weber BK, Wuthrich B, Wangorsch A, Fotisch K, Altmann F, Vieths S. Carrot allergy: double-blinded, placebo-controlled food challenge and identification of allergens. J Allergy Clin Immunol 2001;108:301307.
  • 9
    Bublin M, Radauer C, Wilson IBH, Kraft D, Scheiner O, Breiteneder H et al. Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. FASEB J 2003;17:16971699.
  • 10
    Baker EN, Baker HM. Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 2005;62:25312539.
  • 11
    Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005;62:25492559.
  • 12
    Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005;62:25762587.
  • 13
    Zavaleta N, Figueroa D, Rivera J, Sanchez J, Alfaro S, Lonnerdal B. Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr 2007;44:258264.
  • 14
    Suzuki YA, Kelleher SL, Yalda D, Wu L, Huang J, Huang N et al. Expression, characterization, and biologic activity of recombinant human lactoferrin in rice. J Pediatr Gastroenterol Nutr 2003;36:190199.
  • 15
    Nandi S, Suzuki YA, Jianmin H, Yalda D, Pham P, Liying W et al. Expression of human lactoferrin in transgenic rice grains for the application in infant formula. Plant Sci 2002;163:713722.
  • 16
    Fujiyama K, Sakai Y, Misaki R, Yanagihara I, Honda T, Anzai H et al. N-linked glycan structures of human lactoferrin produced by transgenic rice. Biosci Biotechnol Biochem 2004;68:25652570.
  • 17
    Van Ree R, Cabanes-Macheteau M, Akkerdaas J, Milazzo JP, Loutelier-Bourhis C, Rayon C et al. β(1,2)-xylose and α(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 2000;275:1145111458.
  • 18
    Goodman RE, Vieths S, Sampson HA, Hill D, Ebisawa M, Taylor SL et al. Allergenicity assessment of genetically modified crops - what makes sense? Nat Biotechnol 2008;26:7381.
  • 19
    Vrtala S, Sperr WR, Reimitzer I, Van Ree R, Laffer S, Muller WD et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl p V allergen. J Immunol 1993;151:47734781.
  • 20
    Mari A. Skin test with a timothy grass (Phleum pratense) Pollen extract vs IgE to a timothy extract vs IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003;33:4351.
  • 21
    Mari A, Iacovacci P, Afferni C, Barletta B, Tinghino R, Di Felice G et al. Specific IgE to cross-reactive carbohydrate determinants strongly affect the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol 1999;103:10051011.
  • 22
    Van Der Zee JS, De Groot H, Van Swieten P, Jansen HM, Aalberse RC. Discrepancies between the skin test and IgE antibody assays: study of histamine release, complement activation in vitro, and occurrence of allergen-specific IgG. J Allergy Clin Immunol 1988;82:270281.
  • 23
    Schuurman J, Perdok GJ, Aalberse RC. Mouse/human chimeric antibodies directed to two nonoverlapping epitopes of the house dust mite allergen, Der p 2. Int Arch Allergy Immunol 1997;113:262263.
  • 24
    Kleine Budde I, De Heer PG, Der Zee JS, Aalberse RC. The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum. Int Arch Allergy Immunol 2001;126:277285.
  • 25
    Siraganian RP. Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975;7:283290.
  • 26
    Bindslev-Jensen C, Ballmer-Weber BK, Bengtsson U, Blanco C, Ebner C, Hourihane J et al. Standardization of food challenges in patients with immediate reactions to foods – position paper from the European Academy of Allergology and Clinical Immunology. Allergy 2004;59:690697.
  • 27
    Van Ree R, Aalberse RC. Specific IgE without clinical allergy. J Allergy Clin Immunol 1999;103:10001001.
  • 28
    Bolhaar ST, Zuidmeer L, Ma Y, Ferreira F, Bruijnzeel-Koomen CA, Hoffmann-Sommergruber K et al. A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge. Clin Exp Allergy 2005;35:16381644.
  • 29
    Jin C, Hantusch B, Hemmer W, Stadlmann J, Altmann FAffinity of IgE and IgG against cross-reactive carbohydrate determinants on plant and insect glycoproteins. J Allergy Clin Immunol 2008;121:185190.